Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

Beaver-Visitec recalls six Mini Blades catalogue numbers in Canada over sterility risk

A Type II recall posted by Health Canada covers six catalogue numbers, each spanning more than 20 lots, though the notice gives no unit counts or financial detail.

12 Nov 2026 · Health Canada · Regulator

Beaver-Visitec International (BVI) has pulled certain Mini Blades from the Canadian market after finding that some packaging seals can be left unclosed, so sterility cannot be assured. Health Canada published the recall, reference RA-82949, on 12 November 2026. It gives 2 November as the date the recall began.

The commercial footprint is hard to size from the public record. The notice names six model or catalogue numbers: 364820, 364822, 364823, BEAVER6400, BEAVER6700 and BEAVER6900. Each is tied to more than 20 lot numbers, but the lots are not itemised, and the notice gives no unit volumes, sales figures or cost estimate. It also does not say whether the recall extends beyond Canada.

BVI says the flaw was confirmed by physical investigation, including visual inspection and dye testing. Sampling so far suggests the defect is intermittent, meaning it does not touch every unit in the affected lots. The notice reports no injuries or adverse events. It lists the devices under general and plastic surgery and tells healthcare audiences to contact the manufacturer for more information.

As context, Canada uses the Type II label for products that may cause temporary or medically reversible health effects, or where the chance of serious harm is considered remote.

Why it matters

  • The recall's financial impact cannot be judged yet: the notice gives no unit counts, revenue exposure or remediation costs.
  • Because the defect is intermittent, sampling at lot level may not show which individual units are compromised, which could complicate how customers handle affected stock.
  • The lot lists sit with BVI rather than in the Health Canada notice, so buyers and distributors depend on the manufacturer for the detail needed to identify affected inventory.
  • The notice covers the Canadian recall only, and it does not address whether the same catalogue numbers are affected in other markets.

Official record: Health Canada ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →